Literature DB >> 16174507

Assessment of talar flattening in adult idiopathic clubfoot.

Christian M Bach1, Georg Goebel, Eckart Mayr, Rainer Biedermann, Franz Rachbauer.   

Abstract

BACKGROUND: The radius/length (R/L) ratio was developed to evaluate the convexity of the talar dome in idiopathic clubfoot. However, the index has not been tested for its reliability and reproducibility.
METHODS: The R/L ratio was determined by three independent observers on the radiographs of 21 adult patients with idiopathic clubfoot and 30 adult subjects with normal feet. The reproducibility and the reliability of the R/L ratio were calculated.
RESULTS: For the normal feet the reproducibility and the reliability of the R/L ratio was high (correlation coefficient > 0.87). For the patients with clubfoot, the reliability and reproducibility depended on the severity of talar flattening. For a radius of less than 45 mm the mean intraobserver correlation coefficient was 0.74 (range 0.54 to 0.83) and the mean interobserver correlation coefficient was 0.58 (range 0.49 to 0.75). For a radius of more than 45 mm no statistically significant intraobserver and interobserver correlations were found.
CONCLUSION: The current results indicate that the R/L ratio of talar flattening is reliable and reproducible for mild talar deformity but not for severe flattening (radius of more than 45 mm).

Entities:  

Mesh:

Year:  2005        PMID: 16174507     DOI: 10.1177/107110070502600914

Source DB:  PubMed          Journal:  Foot Ankle Int        ISSN: 1071-1007            Impact factor:   2.827


  2 in total

1.  The impact of different types of talus deformation after treatment of clubfeet.

Authors:  Alexander Kolb; Madeleine Willegger; Reinhard Schuh; Alexandra Kaider; Catharina Chiari; Reinhard Windhager
Journal:  Int Orthop       Date:  2016-10-11       Impact factor: 3.075

2.  Flat Top Talus: Complication of Ponseti Method or Overcorrection?

Authors:  Shahbaz Khan; Mansoor Ali Khan; Muhammad Amin Chinoy; Sadia Ahmed
Journal:  Cureus       Date:  2021-02-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.